Mount Desert Island Biological Lab’s scientists: Kevin Strange, Voot Yin and their collaborator Michael Zasloff have been awarded a patent for MSI-1436, a potential new heart disease drug that stimulates the repair and regeneration of heart tissue damaged by injuries like a heart attack, according to MaineBiz. This is the first patent for the lab. Prof. Kevin Strange, MDIBL’s president says: “The importance of this achievement cannot be overstated. This patent is a critical step forward in our ability to develop new treatments for those who suffer from heart disease (…)”. Read full story
MDI Biological Lab Earns Its First Patent For Heart Repair Medicine
Related Posts
Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming
Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...
UNE retains R2 Research status, reinforcing leadership in scientific advancement
The University of New England has retained its status as one of the country’s leading research universities with the recent release...
Maine college students investigate health effects of forever chemicals
Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...